Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-21

Clinical Trial Update: Efficacy of Ipomea Pes-caprae Ointment as an add-on Therapy in Patient With Jellyfish Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Ipomea Pes-caprae Ointment as an add-on therapy for jellyfish dermatitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ipomea Pes-caprae Ointment

Snippet

Sponsor: Mahidol University | Conditions: Jellyfish Dermatitis, Jellyfish Venoms | Phase 2 | Status: COMPLETED